|
Kate-
I am so sorry to hear of your progression. My mets was first to lungs, and my onc chose xeloda, and I chose the clinial trial if xeloda with tykerb, and that kicked things back quite a bit for some time.
But everyone is differerent, and the navalbine and taxanes are also an option. Like Lolly mentioned, I would definitely keep the herceptin...
Please keep us posted, and you are in our thoughts and prayers...
Kind regards,
__________________
Shell
init diag 3/17/03-stage IIIC
ER-/PR-/HER2+++
CET x4 neo-adjuvant
lump & SNB 8/03
CET x2
radiation and herceptin/navelbine 11-03-1/04
1st reoccur to lymph nodes 8/04
complete axillary dissection 12/04
herceptin/taxotere til progression (lungs) 3/05
xeloda w/out lapatinib trial 6/05
lapatinib/tykerb added 4/06
ended trial 8/06 due to progression
doxil / avastin 11/06-12/06 - wasn't working
navelbine/herceptin/avastin 12/06/3/07 - progression
gemzar/carboplatin/tykerb 4/07
mri shows extensive mets to bone in pelvic area 6/07
switched to abraxane (3 on/1 off) + tykerb 6/07
|